Biotech Cos. Must Respect Coexisting Gene Editing Patents

By Tyler Cho, John Emanuele, Roberta Hanson and David Walker
September 18, 2018, 2:53 PM EDT

A legal dispute over the fundamental patent rights to CRISPR-Cas9 gene editing technology might be coming to an end. On Monday, Sept. 10, the U.S. Court of Appeals for the Federal...

Already a subscriber? Click here to view full article